For the study ... show. The findings were published Monday in the Annals of Internal Medicine. There has been a notable uptick in GLP-1 use since 2020, Rezaie noted. The U.S. Food and Drug ...

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...

A growing number of people with type 1 diabetes are becoming overweight or obese, in part because insulin can cause weight ...

Semaglutide did not increase the risk of depression, suicidal thoughts or suicidal behavior in people without known mental ...

Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule ...

As this published study notes, the level of expected weight loss associated with GLP-1 drugs is directly correlated ... effects arising from the testing or use of products utilizing the ...

Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic shift these medications will have on the industry.

Amid an ongoing debate over what role, if any, GLP-1 medications should play in treating children who are still in elementary ...